UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 12, 2017
Accession Number:
Submission Type:
CIK:
0001582554
Company Name:
Matinas BioPharma Holdings, Inc.
File Number:
333-217106